Skip to main content
. 2020 Oct 13;21:264. doi: 10.1186/s12931-020-01503-z

Fig. 2.

Fig. 2

Study design. aPatients who enrol in the extension study on the same day as the end-of-treatment visit in SOURCE will not attend follow-up visits at week 54 and week 60. OCS, oral corticosteroids; Q4W, every 4 weeks; s.c., subcutaneous